European Journal of Cancer Supplements
(EJC SUPPL) 《欧洲癌症杂志增刊》
网友评分点击次数：1935
2013年影响因子
0
推荐阅读
- 2013-06-22•BCLC治疗方法和选择性内放射治疗地位
- 2013-06-22•ENRY分析：一项325名患者欧洲多中心分析
- 2013-06-22•选择性内放射治疗一线治疗– SIRFLOX 和 FOXFIRE
- 2013-06-22•结直肠癌选择性内放射治疗未来方向
- 2013-06-22•二线选择性内放射治疗整合： InSIR试验
- 2013-06-22•化疗抵抗结直肠癌治疗进展
目录导读
Published 2013年8月,Volume 10,Issue 3
最新一期
| Article Title | Author(s) | Pages | ||
|---|---|---|---|---|
Editorial Board
|
ii | |||
| Chapter 1: Selective internal radiation therapy for patients with colorectal liver metastases | ||||
| Article Title | Author(s) | Pages | ||
State of the art – colorectal liver metastases
|
Philippe Rougier | 2-3 | ||
Synergy of yttrium-90 microspheres therapy with radiosensitising chemotherapy
|
Ricky A. Sharma | 4-6 | ||
Progress in the management of chemorefractory colorectal cancer
|
Eric Van Cutsem | 7-9 | ||
Integration of selective internal radiation therapy second-line: The InSIRT trial
|
Tony R. Reid | 10-11 | ||
Selective internal radiation therapy first-line therapy – SIRFLOX and FOXFIRE
|
Harpreet S. Wasan | 12-14 | ||
Future directions for selective internal radiation therapy in colorectal cancer
|
Marc Peeters | 15-17 | ||
| Chapter 2: The emerging role of selective internal radiation therapy in hepatocellular carcinoma | ||||
| Article Title | Author(s) | Pages | ||
State of the art – hepatocellular carcinoma
|
Olivier Rosmorduc | 20-22 | ||
The ENRY analysis: a 325-patient European multicentre analysis
|
Bruno Sangro | 23-26 | ||
BCLC treatment algorithm and the place of selective internal radiation therapy
|
Frank T. Kolligs | 27-29 | ||
Evolving clinical evidence for selective internal radiation therapy in hepatocellular carcinoma
|
Pierce Chow, Jens Ricke, P. Malfertheiner, Valérie Vilgrain | 30-33 | ||
| Chapter 3: Selective internal radiation therapy – downsizing liver tumours to resection, ablation or transplantation | ||||
| Article Title | Author(s) | Pages | ||
Liver resection post-selective internal radiation therapy – an overview
|
David P. Berry | 36-38 | ||
Hepatocellular carcinoma resection post-selective internal radiation therapy
|
Joseph W.-Y. Lau | 39-40 | ||
Bridging and downstaging to transplantation in HCC
|
G.M. Ettorre, G. Vennarecci, R. Santoro, P. Lepiane, et al. | 41-43 | ||
Hypertrophy of the contralateral hepatic lobe after selective internal radiation therapy
|
Hojjat Ahmadzadehfar, Carsten Meyer, Samer Ezziddin, Amir Sabet, et al. | 44-45 | ||
| Chapter 4: Optimising patient outcomes from work-up to follow-up | ||||
| Article Title | Author(s) | Pages | ||
Overview of selective internal radiation therapy: from work-up to follow-up
|
Thomas Helmberger | 48-50 | ||
Maximising effects and minimising complications of selective internal radiation therapy
|
José Ignacio Bilbao | 51-53 | ||
Selective internal radiation therapy simulation using 99mTc-labelled macroaggregates of albumin and SPECT-CT
|
Patrick Flamen, Alain Hendlisz, Bruno Vanderlinden | 54-56 | ||
Measuring the response to selective internal radiation therapy
|
Jens Ricke | 57-58 | ||
Calculating yttrium-90 activity with clinical considerations
|
Andrew S. Kennedy | 59-61 | ||
| Chapter 5: Selective internal radiation therapy for neuroendocrine tumours, cholangiocarcinoma and tumours of various other origins | ||||
| Article Title | Author(s) | Pages | ||
Overview of neuroendocrine liver metastases treatment
|
Philippe Ruszniewski | 64-66 | ||
Selective internal radiation therapy for neuroendocrine liver metastases
|
Lourens Bester | 67-69 | ||
Selective internal radiation therapy for cholangiocarcinoma
|
Frank T. Kolligs | 70-71 | ||
Selective internal radiation therapy for other liver metastases
|
Tobias Jakobs | 72-74 | ||
| Chapter 6: Patient selection criteria | ||||
| Article Title | Author(s) | Pages | ||
Patient selection criteria for selective internal radiation therapy and integration into treatment guidelines
|
Harpreet S. Wasan, Bruno Sangro, Andrew S. Kennedy | 76-80 | ||
发表评论网友评论(13)
